MedPath

Evaluating the effectiveness of the traditional vaginal product on vulvovaginal atrophy

Phase 2
Recruiting
Conditions
Vulvovaginal atrophy.
N95.2
Postmenopausal atrophic vaginitis
Registration Number
IRCT20191210045687N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Having a patient's consent to participate in the project
Ability to fill out forms and questionnaires alone or with the help of a researcher
18 years or older
Married
Menopause
History of breast cancer
Hormonal treatment history
Having subjective symptoms of vulvovaginal atrophy (itching, burning, dryness, dyspareunia) with a minimal sum score of 3

Exclusion Criteria

Having multiple sex partners
Acute psychiatric illness and antidepressant use during the last month
Other cancers at the same time as breast cancer
Incomplete chemotherapy and radiotherapy
Use of lubricant or vaginal moisturizer and other vaginal medications during the last month
Not having a negative Pap smear over the last year

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath